US News

Amgen Wins Approval for Pathbreaking Lung Cancer Drug

A potential blockbuster, the drug is the first to treat a common cancer mutation called KRAS that researchers struggled for years to target.

Jump To The Original Source

Facebook Comments

Check Also

U.S. Democrats scramble to hammer out climate legislation ahead of Glasgow talks

Published by Reuters By Jarrett Renshaw, Jeff Mason ...

Archives